Timestamps - Mrkcap £14m at 55p
00:00 - How the LungLB diagnostic works, and what problem it solves.
03:55 - Its accuracy vs the existing standard of care.
05:25 - Size of addressable market.
09:45 - Progress of 425 person validation study.
11:05 - Significance of the LungLB peer reviewed pilot trial & cost-effectiveness health economics report.
13:50 - Commercialisation strategy.
19:45 - Future R&D roadmap.
21:20 - Funding runway & long term opportunity
Disclosure: Vox Markets paid me to interview Lunglife AI
